It has been hypothesized that women who metabolize their endogenous estroge
ns predominantly via 16(alpha)- hydroxylation rather than via 2-hydroxylati
on and, as a result, have a low ratio of 2-hydroxyestrone (2-OHE1): 16(alph
a)-hydroxyestrone (16(alpha)-OHE1) are at an increased risk of breast cance
r. Epidemiological evidence in support of this hypothesis is scarce and mos
tly based on measurements made after the onset of the disease. To gain insi
ght into the role of these metabolites in the etiology of breast cancer, we
assessed their relationship with high-density Wolfe mammographic parenchym
al patterns (P2/DY), a recognized indicator of risk of this tumor. The stud
y was nested within a large cross-sectional survey on determinants of mammo
graphic patterns carried out in a population-based breast screening program
in Northern Greece. Urinary levels of 2-OHE1 and 16(alpha)-OHE1 were measu
red in a random sample of 70 postmenopausal women with P2/DY mammographic p
atterns and in a random sample of 70 women with N1 mammographic patterns, i
ndividually matched to the P2/DY women on year of birth, years since menopa
use and date of urine collection. Women with a P2/DY pattern had, on averag
e, 58% higher levels of 2-OHE1 (P = 0.002) and 15% higher levels of 16(alph
a)- OHE1 (P = 0.37) than those with an N1 pattern. The ratio of 2-OHE1:16(a
lpha)-OHE1 was 35% higher (P = 0.005) in women with a P2/DY pattern. Women
in the highest one-third of this ratio were six times more likely to have a
P2/DY pattern than those in the lowest one-third after adjusting for poten
tial confounders (prevalence odds ratio, 6.2; 95% CI, 1.7-22.9; test for li
near trend, P = 0.002). These findings seem to suggest that a high, rather
than a low, 2-OHE1:16(alpha)-OHE1 ratio may be associated with an increase
in breast cancer risk at postmenopausal ages, unless the pathway through wh
ich estrogen metabolites may affect breast cancer risk is unrelated to mamm
ographic parenchymal patterns.